General Announcement::Press Release

Issuer & Securities

Issuer/ Manager
BIOCON BIOLOGICS GLOBAL PLC
Securities
BIOCONBIO US$800M6.67%N291009A - US090978AA56 - RJUB
BIOCONBIO US$800M6.67%N291009R - USG11185AA61 - KSEB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
12-Dec-2024 01:54:13
Status
New
Announcement Sub Title
Press Release
Announcement Reference
SG241212OTHREC1X
Submitted By (Co./ Ind. Name)
Biocon Biologics Limited/ Akhilesh Nand
Designation
Company Secretary
Effective Date and Time of the event
11/12/2024 17:00:00
Description (Please provide a detailed description of the event in the box below)
Biocon Biologics Recognized as Asia IP Elite for 2024 by IAM, Cementing Leadership in Intellectual Property Excellence.

Attachments

BBL_SGX_PR_11122024.pdf
Total size =444K